Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor.


Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
06 2021
Historique:
received: 01 10 2020
accepted: 12 12 2020
revised: 10 12 2020
pubmed: 4 1 2021
medline: 22 6 2021
entrez: 3 1 2021
Statut: ppublish

Résumé

To evaluate various imaging features on magnetic resonance imaging (MRI) and tumor markers and their utility to assess various grades of ovarian primary mucinous tumors (OPMTs): benign, borderline, or malignant. Ninety-five pathologically diagnosed OPMTs [53 benign, 24 borderline malignant (BM), and 18 malignant] were selected in this retrospective study. MRI features of the ovarian mass, namely the maximum diameter, honeycomb loculi, solid components (SC), stained-glass pattern, and signal intensity of the cyst on T1- (T1WI) and T2-weighted imaging (T2WI) with/without fat suppression, and preoperative STMs, namely carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, and CA125, were compared between the three tumor grades using univariate analysis. We also analyzed the findings to estimate the pathological diagnosis using classification tree (CT) analysis. Maximum diameter, honeycomb loculi, SC, stained-glass pattern, signal intensity of the cyst [hyperintensity on both T1WI and T2WI (T1-hyper/T2-hyper), and hyperintense on T1WI and hypointense on T2WI (T1-hyper/T2-hypo)], and CEA and CA 19-9 concentrations were significantly different between the three tumor grades (p < 0.05). The concordance rate with the pathological diagnosis was the highest with diagnosis by the CT comprising T1-hyper/T2-hypo, CEA, and CA 19-9 and by the CT comprising T1-hyper/T2-hypo, CEA, and SC. Four types of findings were important for OPMT grading. Lesions negative for both T1-hyper/T2-hypo and CEA suggest benign; lesions positive for T1-hyper/T2-hypo and negative for CA 19-9 or SC suggest BM; and lesions negative for T1-hyper/T2-hypo and positive for CEA, or positive for both T1-hyper/T2-hypo and CA 19-9 or SC suggest malignancy.

Identifiants

pubmed: 33388806
doi: 10.1007/s00261-020-02918-4
pii: 10.1007/s00261-020-02918-4
doi:

Substances chimiques

CA-125 Antigen 0
CA-19-9 Antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2393-2402

Références

Kurman RJ, Carcangiu ML, Herrington S, Young RH (2014) WHO Classification of Tumours of Female Reproductive Organs 4th ed. IARC Publications, Lyon
Okamoto Y, Tanaka YO, Tsunoda H, Yoshikawa H, Minami M (2007) Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging 26:94–99
doi: 10.1002/jmri.20948
Ma FH, Zhao SH, Qiang JW, Zhang GF, Wang XZ, Wang L (2014) MRI appearances of mucinous borderline ovarian tumors: pathological correlation. J Magn Reson Imaging 40:745–751
doi: 10.1002/jmri.24408
Zhao SH, Qiang JW, Zhang GF, Wang SJ, Qiu HY, Wang L (2014) MRI in differentiating ovarian borderline from benign mucinous cystadenoma: pathological correlation. J Magn Reson Imaging 39:162–166
doi: 10.1002/jmri.24083
Neunteufel W, Breitenecker G (1989) Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA. Gynecol Oncol 32:297–302
doi: 10.1016/0090-8258(89)90628-8
Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, Yoshikawa H, Minami M (2016) Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis. Cancer Imaging 16:3
doi: 10.1186/s40644-016-0061-9
Ye C, Ito K, Komatsu Y, Takagi H (1994) Extremely high levels of CA19-9 and CA125 antigen in benign mucinous ovarian cystadenoma. Gynecol Oncol 52:267–271
doi: 10.1006/gyno.1994.1044
Chen F, Shen J, Wang J, Cal P, Huang Y (2018) Clinical analysis of four serum markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors. Cancer Manag Res 10:1313–1318
doi: 10.2147/CMAR.S155693
Lin W, Cao D, Shen K (2018) Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study. Cancer Manag Res 10:6913–6920
doi: 10.2147/CMAR.S186258
Santotoribio JD, Garcia-de la Torre A, Cañavate-Solano C, Arce-Matute F, Sanchez-del Pino MJ, Perez-Ramos S (2016) Cancer antigens 19.9 and 125 as tumor makers in patients with mucinous ovarian tumors. Eur J Gynaecol Oncol 37:26–29
pubmed: 27048105
Lerkhachonsuk AA, Buranawongtrakoon S, Lekskul N, Rermluk N, Wee-Stekly WW, Charakorn C (2020) Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors. J Obstet Gynaecol Res https://doi.org/10.1111/jog.14427
doi: 10.1111/jog.14427
Renzulli M, Biselli M, Brocchi S, et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682
doi: 10.1136/gutjnl-2017-315384
Jansen MJA, Kuijf HJ, Veldhuis WB, Wessels FJ, Viergever MA, Pluim JPW (2019) Automatic classification of focal liver lesions based on MRI and risk factors. PLoS ONE 14:e0217053
doi: 10.1371/journal.pone.0217053
Tanaka YO, Nishida M, Kurosaki Y, Itai Y, Tsunoda H, Kubo T (1999) Differential diagnosis of gynecological “stained grass” tumours on MRI. Br J Radiol 72:414–420
doi: 10.1259/bjr.72.856.10474509
Tanaka Y, Nakai G, Yamamura K, Yamamoto K, Narumi Y, Ohmichi M (2019) Analysis of MRI values and hemoglobin and total protein concentrations of cystic ovarian tumors. J Magn Reson Imaging 49:1133–1140
doi: 10.1002/jmri.26299
Anzalone N, Scotti R, Riva R (2004) Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 25:S3–S5
doi: 10.1007/s10072-004-0205-8
Hayashi Y, Tachibana O, Muramatsu N, et al (1999) Rathke cleft cyst: MR and biomedical analysis of cyst content. J Comput Assist Tomogr 23:34–38
doi: 10.1097/00004728-199901000-00008
Ghossain MA, Buy JN, Ligneres C, et al (1991) Epithelial tumors of the ovary: comparison of MR and CT findings. Radiology 181:863–870
doi: 10.1148/radiology.181.3.1947112
Outwater EK, Huang AB, Dunton CJ, Talerman A, Capuzzi DM (1997) Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging 7:689–695
doi: 10.1002/jmri.1880070414

Auteurs

Ayumi Ohya (A)

Department of Radiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. ayumiayu@shinshu-u.ac.jp.

Fumihito Ichinohe (F)

Department of Radiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Hisanori Matoba (H)

Department of Molecular Pathology, Shinshu University Graduate School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Hisanori Kobara (H)

Department of Obstetrics and Gynecology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Yasunari Fujinaga (Y)

Department of Radiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH